Simplex Trading
ABCL icon

Simplex Trading’s AbCellera Biologics ABCL Stock Holding History

Simplex Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$458K Buy
31,395
+11,895
+61% +$113K ﹤0.01% 3670
2026
Q2 		$153K Sell
19,500
-181,736
-90% -$888K ﹤0.01% 5051
2026
Q1 		$702K Buy
+201,236
New +$724K ﹤0.01% 2880
2025
Q4 		– Sell
-68,077
Closed -$304K – 8347
2025
Q3 		$342K Buy
+68,077
New +$300K ﹤0.01% 4299
2025
Q1 		– Sell
-6,176
Closed -$17.7K – 8368
2024
Q4 		$18K Sell
6,176
-58,007
-90% -$162K ﹤0.01% 6746
2024
Q3 		$166K Buy
64,183
+26,998
+73% +$74.8K ﹤0.01% 4703
2024
Q2 		$110K Sell
37,185
-16,289
-30% -$61.6K ﹤0.01% 5279
2024
Q1 		$242K Sell
53,474
-3,386
-6% -$17.3K ﹤0.01% 4640
2023
Q4 		$324K Buy
56,860
+52,851
+1,318% +$245K ﹤0.01% 4135
2023
Q3 		$18K Sell
4,009
-1,453
-27% -$8.84K ﹤0.01% 6689
2023
Q2 		$35K Sell
5,462
-5,885
-52% -$40.2K ﹤0.01% 6169
2023
Q1 		$85K Sell
11,347
-89,144
-89% -$809K ﹤0.01% 5325
2022
Q4 		$1.02M Buy
100,491
+39,705
+65% +$459K ﹤0.01% 2445
2022
Q3 		$601K Buy
60,786
+36,004
+145% +$395K ﹤0.01% 3254
2022
Q2 		$263K Sell
24,782
-26,174
-51% -$222K ﹤0.01% 4267
2022
Q1 		$496K Sell
50,956
-34,468
-40% -$326K ﹤0.01% 3853
2021
Q4 		$1.22M Buy
85,424
+57,142
+202% +$867K ﹤0.01% 2602
2021
Q3 		$581K Buy
28,282
+960
+4% +$17K ﹤0.01% 3863
2021
Q2 		$601K Buy
27,322
+24,152
+762% +$666K ﹤0.01% 3878
2021
Q1 		$107K Buy
+3,170
New +$126K ﹤0.01% 5644

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Simplex Trading's ABCL Position: Q3 2026 in Review

Simplex Trading increased its AbCellera Biologics (ABCL) stake by 61% in Q3 2026, buying an estimated $113K and bringing the position to 31,395 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #3670.

Simplex Trading first reported a position in ABCL in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.22M in Q4 2021. 64 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • Simplex Trading held 31,395 shares of AbCellera Biologics worth $458K as of Q3 2026.
  • Simplex Trading bought 11,895 AbCellera Biologics shares in Q3 2026, an estimated $113K.
  • AbCellera Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #3670 holding.
  • Simplex Trading first reported a position in AbCellera Biologics in Q1 2021 and has held it in 20 quarters since.
  • Simplex Trading's AbCellera Biologics position peaked at $1.22M in Q4 2021.
  • 64 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.